Kfir Molakandov - 18 Mar 2026 Form 3 Insider Report for NewcelX Ltd. (NCEL)

Role: VP of R&D
Signature: /s/ Kfir Molakandov
Issuer symbol: NCEL
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 06:57:20 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Molakandov Kfir	VP of R&D	C/O NEWCELX LTD., THE CIRCLE 6, ZURICH, SWITZERLAND	/s/ Kfir Molakandov	18 Mar 2026	0002120197

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NCEL	Option to Purchase Ordinary Shares							18 Mar 2026	Ordinary Shares	11,396	$7.62	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As of the date of this Form 3, options to purchase 949 ordinary shares are vested and currently exercisable. The remaining options vest and become exercisable beginning on May 4, 2026 in 11 equal installments on a quarterly basis, subject to the Reporting Person's continued service.
F2	To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in the name of a trustee.